MACAU LEGEND (01680) suggests canceling the share premium account and capital restructuring.
Macau Lai Jun (01680) announced that the board of directors has recommended the cancellation of all income from the premium on the company's share capital account, and to be registered...
MACAU LEGEND (01680) announced that the board of directors proposed to cancel all amounts received in the share premium account, and to transfer the amounts generated from the cancellation to an account designated as the companys paid-up surplus account before the change of jurisdiction takes effect. After the change of jurisdiction takes effect, the company proposes to implement a capital reorganization, which includes the following:
(i) Reduction of share capital, by cancelling the paid-up capital of HK$0.99 per share issued and reducing the nominal or face value of each issued share from HK$1.00 to HK$0.01 per share, thereby reducing the issued share capital of the company;
(ii) Splitting of shares following the reduction of share capital, by splitting the unissued shares with a nominal value of HK$1.00 per share into 100 new shares with a nominal value of HK$0.01 per share;
(iii) Amounts generated from the reduction of share capital will be transferred to the companys paid-up surplus account; and
(iv) Amounts in the paid-up surplus account will be used to offset accumulated losses in a manner permitted by all applicable laws and rules in effect from time to time and deemed appropriate by the board of directors.
Related Articles

US Stock Market Move | Mexican airline (AERO.US) landed on the US stock market and opened with a rise of more than 2.8%.

US Stock Market Move | Biopharmaceutical company Evommune (EVMN.US) debuts on the US stock market with a stock price surge of over 15%.

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.
US Stock Market Move | Mexican airline (AERO.US) landed on the US stock market and opened with a rise of more than 2.8%.

US Stock Market Move | Biopharmaceutical company Evommune (EVMN.US) debuts on the US stock market with a stock price surge of over 15%.

US Stock Market Move | BEIGENE (ONC.US) rose more than 3% with third-quarter revenue breaking 10 billion and raising its 2025 performance guidance.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


